This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2026 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.86% per year. These returns cover a period from January 1, 1988 through February 2, 2026. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
View the Zacks #1 Rank List
medical-devices: Archive
Intuitive Surgical or Abbott: Which MedTech Stock Is a Better Bet Now?
by Indrajit Bandyopadhyay
Both ISRG and ABT closed 2025 on a strong note, but Intuitive Surgical's surging procedure growth and innovation may give it the edge for long-term gains.
ABTNegative Net Change ISRGNegative Net Change
medical medical-devices
HOLX vs. GEHC: Which Women's Health Stock Should You Pick Now?
by Moumi Mondal
GE HealthCare is gaining ground with strong backlog, AI-driven imaging advances and rising service capture, while Hologic's buyout caps near-term upside.
HOLXPositive Net Change GEHCNegative Net Change
medical medical-devices
After Golden Cross, CMS Energy (CMS)'s Technical Outlook is Bright
by Zacks Equity Research
Should investors be excited or worried when a stock's 50-day simple moving average crosses above the 200-day simple moving average?
CMSPositive Net Change
ad-tech artificial-intelligence automation autonomous-vehicles batteries biotechnology cell-therapy creator-economy crispr daily-movers dna-sequencing electric-vehicles fin-tech furniture-retailers gambling gene-editing gene-therapy genetic-testing genomics home-builder home-buying-apps immuno-therapy iot medical-devices messenger-rna mobile moving-average-crossover oncology-screening payments ride-hailing robotics saas self-driving-cars smart-health social-media stock-price-movement stocks-moving-today vaccines
Merit Medical Q4 Earnings & Revenues Beat Estimate, Margins Expand
by Zacks Equity Research
MMSI beats Q4 estimates as EPS climbs 12% and margins widen, driven by strong Cardiovascular growth and solid U.S. and EMEA sales.
ISRGNegative Net Change CAHPositive Net Change MMSINegative Net Change VCYTNegative Net Change
earnings medical medical-devices
FMS Stock Rises as Q4 Earnings & Sales Beat Estimates, Margins Expand
by Zacks Equity Research
FMS tops Q4 estimates as EPS jumps 59% and margins expand, powered by savings from its FME25+ program despite portfolio-optimization-driven sales pressure.
ISRGNegative Net Change CAHPositive Net Change FMSPositive Net Change VCYTNegative Net Change
earnings medical medical-devices
Avanos Medical Stock Dips Despite Q4 Earnings Beat, Revenues Up Y/Y
by Zacks Equity Research
AVNS shares plunge 10% even after a Q4 earnings and revenue beat, as margin pressure and tariff concerns weigh on investors.
CAHPositive Net Change MCKPositive Net Change AVNSNegative Net Change GEHCNegative Net Change
earnings medical medical-devices
Inogen Stock Dips Despite Q4 Earnings Beat, Revenues Up Y/Y
by Zacks Equity Research
INGN posts narrower Q4 loss and 2% revenue rise, but shares dip as U.S. sales and rentals weaken despite international strength.
CAHPositive Net Change MCKPositive Net Change INGNPositive Net Change GEHCNegative Net Change
earnings medical medical-devices
HIMS vs. AMWL: Which Telehealth Stock Is the Better Investment Now?
by Debanjana Dey
Hims & Hers and Amwell are taking different paths in telehealth, but which stock offers the stronger opportunity today? Let's dive in.
AMWLNegative Net Change HIMSPositive Net Change
medical medical-devices
Stryker Launches Synchfix EVT for Flexible Syndesmotic Fixation
by Zacks Equity Research
SYK launches Synchfix EVT, a next-gen ankle fixation system designed to streamline surgery and expand reach into adolescent trauma care.
SYKNegative Net Change ISRGNegative Net Change VCYTNegative Net Change GEHCNegative Net Change
medical medical-devices
TMDX Stock Rises as Q4 Earnings & Revenues Beat Estimates
by Zacks Equity Research
TransMedics posts 200% EPS surge and 32% revenue growth in Q4, tops estimates and guides for up to 25% sales growth in 2026.
ANGONegative Net Change ISRGNegative Net Change PACBNegative Net Change TMDXPositive Net Change
earnings medical medical-devices